Acontroversial new drug for Alzheimer’s disease is raising tough questions: Who should take it? Who will pay for it? And how will we know how well it works? But that’s not the only Alzheimer’s news during Alzheimer’s and Brain Awareness Month. Recent USC research shows that members of an isolated indigenous group in the Bolivian […]